XBRL Cloud: Business Report

Rendering

Component: (Network and Table)
Network	120 - Disclosure - Summary of Significant Accounting Policies (Tables) (http://www.icad.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables)
Table	(Implied)

Slicers (applies to each fact value in each table cell)

Reporting Entity [Axis]

0000749660 (http://www.sec.gov/CIK)

Accounting Policies [Abstract]

Period [Axis]

2016-01-01 - 2016-12-31

Accounting Policies [Abstract]

Schedule of Allowance for Doubtful Accounts

The following table summarizes the allowance for doubtful accounts for the three years ended December 31, 2016 (in thousands):


	2016			2015			2014
Balance at beginning of period	$	236		$	203		$	73
Additions charged to costs and expenses		177			383			167
Reductions		(241	)		(350	)		(37	)

Balance at end of period	$	172		$	236		$	203

Schedule of Current Inventory

At December 31, 2016 and 2015, inventories consisted of the following (in thousands):


	As of December 31,
	2016		2015
Raw materials	$	2,503	$	2,900
Work in process		75		154
Finished Goods		1,149		1,261

Inventory	$	3,727	$	4,315

Schedule of Property and Equipment Estimated Useful Lives

Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets or the remaining lease term, if shorter, for leasehold improvements (see below).


		Estimated life
Equipment		3-5 years
Leasehold improvements		3-5 years
Furniture and fixtures		3-5 years
Marketing assets		3-5 years

Schedule of Intangible Assets

A summary of intangible assets for 2016 and 2015 are as follows (in thousands):


	2016		2015		Weighted average useful life
Gross Carrying Amount
Patents and licenses	$	583	$	579		5 years
Technology		9,567		14,075		10 years
Customer relationships		292		268		7 years
Tradename		259		248		10 years

Total amortizable intangible assets		10,701		15,170

Accumulated Amortization
Patents and licenses	$	477	$	451
Technology		6,754		9,996
Customer relationships		28		201
Tradename		259		248

Total accumulated amortization		7,518		10,896

Total amortizable intangible assets, net	$	3,183	$	4,274

Schedule of Expected Amortization Expense

Estimated remaining amortization of the Company’s intangible assets is as follows (in thousands):


For the years ended December 31:	Estimated amortization expense
2017	$	574
2018		511
2019		499
2020		370
2021		311
Thereafter		918

	$	3,183

Roll Forward of Goodwill Activity by Reportable Segment

A rollforward of goodwill activity by reportable segment is as follows (in thousands):


	Detection			Therapy			Total
Accumulated Goodwill	$	—		$	—		$	47,937
Accumulated impairment		—			—			(26,828	)

Fair value allocation		7,663			13,446			—
Acquisition of DermEbx and Radion		—			6,154			6,154

Balance at December 31, 2014		7,663			19,600			27,263

Acquisition measurement period adjustments		—			116			116
Acquisition of VuComp		800			—			800
Impairment		—			(13,981	)		(13,981	)

Balance at December 31, 2015		8,463			5,735			14,198

Acquisition of VuComp		293			—			293
Sale of MRI assets		(394	)		—			(394	)

Balance at December 31, 2016	$	8,362		$	5,735		$	14,097

Accumulated Goodwill		699			6,270			54,906
Fair value allocation		7,663			13,446			—
Accumulated impairment		—			(13,981	)		(40,809	)

Balance at December 31, 2016	$	8,362		$	5,735		$	14,097

Roll forward of Warranty Cost

Warranty provisions and claims for the years ended December 31, 2016, 2015 and 2014, were as follows (in thousands):


	2016			2015			2014
Beginning accrual balance	$	19		$	14		$	25
Warranty provision		47			54			58
Usage		(55	)		(49	)		(69	)

Ending accrual balance	$	11		$	19		$	14

Calculation of Net Loss Per Share

A summary of the Company’s calculation of net loss per share is as follows (in thousands, except per share amounts):


	2016			2015			2014
Net loss available to common shareholders	$	(10,099	)	$	(32,447	)	$	(1,009	)

Basic shares used in the calculation of earnings per share		15,932			15,686			14,096
Effect of dilutive securities:
Stock options		—			—			—
Restricted stock		—			—			—

Diluted shares used in the calculation of earnings per share		15,932			15,686			14,096

Net loss per share :
Basic	$	(0.63	)	$	(2.07	)	$	(0.07	)
Diluted	$	(0.63	)	$	(2.07	)	$	(0.07	)

Schedule of Anti-dilutive Shares Excluded from Computation of Diluted Net Loss Per Share

The following table summarizes the number of shares of common stock for securities, warrants and restricted stock that were not included in the calculation of diluted net loss per share because such shares are antidilutive:


	2016		2015		2014
Common stock options		1,425,348		1,571,998		1,417,887
Restricted Stock		511,398		516,396		309,317

		1,936,746		2,088,394		1,727,204

Assets which are Measured at Fair Value on a Recurring Basis

The following table sets forth Company’s assets which are measured at fair value on a recurring basis by level within the fair value hierarchy.


Fair value measurements using: (000’s) as of December 31, 2016
	Level 1		Level 2		Level 3		Total
Assets
Money market accounts	$	6,622	$	—	$	—	$	6,622

Total Assets	$	6,622	$	—	$	—	$	6,622


Fair value measurements using: (000’s) as of December 31, 2015
	Level 1		Level 2		Level 3		Total
Assets
Money market accounts	$	13,577	$	—	$	—	$	13,577

Total Assets	$	13,577	$	—	$	—	$	13,577